Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

11.8%

4 terminated out of 34 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

35%

12 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed with results

Key Signals

5 with results80% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (3)
P 1 (2)
P 2 (16)
P 3 (9)
P 4 (3)

Trial Status

Completed16
Unknown6
Recruiting5
Terminated4
Not Yet Recruiting2
Withdrawn1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT06532279Phase 2Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT03581773Phase 2Recruiting

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

NCT07543978Phase 3Not Yet Recruiting

Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis (RTOM)

NCT07506018Not ApplicableRecruitingPrimary

MucoLock™ for Treatment of Stomatitis

NCT07400328Phase 2Recruiting

Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients

NCT07357597Phase 4Not Yet RecruitingPrimary

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

NCT07322666Not ApplicableCompletedPrimary

Non-Thermal Plasma vs. Low-Level Laser Therapy for Recurrent Oral Ulcers

NCT05878405Phase 3Completed

Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer

NCT06071637Phase 3Recruiting

Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT

NCT03200340Phase 2CompletedPrimary

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

NCT03469284Phase 2Completed

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

NCT02229136Phase 2CompletedPrimary

Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus

NCT02531906Phase 1Completed

Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation

NCT05323058Phase 2UnknownPrimary

The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy

NCT01288625Phase 4Withdrawn

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

NCT05010928Phase 2UnknownPrimary

Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers

NCT01092975Phase 1Terminated

Safety of Phenylephrine for Oral Mucositis Prevention

NCT03778008Phase 2UnknownPrimary

Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis

NCT02326675Not ApplicableTerminated

Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant

NCT00031551Phase 2TerminatedPrimary

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

Scroll to load more

Research Network

Activity Timeline